학술논문

Phase IB Study of GITR Agonist Antibody TRX518 Singly and in Combination with Gemcitabine, Pembrolizumab, or Nivolumab in Patients with Advanced Solid Tumors
Document Type
Journal
Source
CLINICAL CANCER RESEARCH; SEP 15 2022, 28 18, p3990-p4002, 13p.
Subject
Language
English
ISSN
15573265